Skip to main content
. 2022 Mar;11(2):106–119. doi: 10.21037/acs-2021-pte-10

Table 1. Risk factors predisposing to CTEPH.

Clinical conditions predisposing to CTEPH
   Large pulmonary emboli
   Recurrent pulmonary emboli
   Insufficient anticoagulation
   Underlying autoimmune and haematological disorders
   Ventriculo-atrial shunts
   Infected pacemaker leads
   Implantable chambers for intravenous chemotherapy (especially when infected)
   Totally implantable central venous access systems
   Splenectomy
   Cancer and chronic myeloproliferative disorders
   Thyroid replacement therapy
Biological risk factors predisposing to CTEPH
   Non-O blood group
   Presence of lupus anticoagulant/antiphospholipid antibodies*

*, interestingly, the classical hereditary thrombotic risk factors, e.g., protein C, protein S and antithrombin deficiencies and mutations of factor V and II are not more frequent in patients with CTEPH, compared with healthy controls and patients with pulmonary arterial hypertension. CTEPH, chronic thromboembolic pulmonary hypertension.